Ketoprofen
Clinical data | |
---|---|
Trade names | Oruvail, others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a686014 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, topical, intravenous |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Protein binding | 99% |
Elimination half-life | 2–2.5 hours |
Identifiers | |
| |
JSmol) | |
Chirality | Racemic mixture |
| |
| |
(what is this?) (verify) |
Ketoprofen is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID) with analgesic and antipyretic effects.[3] It acts by inhibiting the body's production of prostaglandin.
It was patented in 1967 and approved for medical use in 1980.[4]
Medical uses
Ketoprofen is generally prescribed for arthritis-related inflammatory pains or severe toothaches that result in the inflammation of the gums.
Ketoprofen topical patches are being used for treatment of musculoskeletal pain.[5][6][7]
Ketoprofen can also be used for treatment of some pain, especially nerve pain such as
Trials are going on for using this drug along with ibuprofen for management of lymphedema.[citation needed] Animal trial and some human trials have shown significant improvement over placebo control. Dr Stanley G Rockson, of Stanford University is leading these researches.[citation needed]
Efficacy
A 2013
There is evidence supporting topical ketoprofen for osteoarthritis but not other chronic musculoskeletal pain.[10]
Adverse effects
In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in fetuses that result in low amniotic fluid.[11][12] They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.[11][12]
Mechanism
Ketoprofen undergoes metabolism in the liver via conjugation with glucuronic acid (glucuronidation) by UGT enzymes, hydroxylation of the benzoyl ring by the CYP3A4 and CYP2C9 enzymes, and reduction of its ketone moiety (a carbonyl functional group, i.e. with carbon-oxygen double bond)[13] by carbonyl reducing enzymes (CREs).[14][15] Ketoprofen is used for its antipyretic, analgesic, and anti-inflammatory properties by inhibiting cyclooxygenase-1 and -2 (COX-1 and COX-2) enzymes reversibly, which decreases production of proinflammatory prostaglandin precursors.[14][16]
The patches have been shown to provide rapid and sustained delivery to underlying tissues without significantly increasing levels of drug concentration in the blood when compared to the traditional oral administration.[7][17]
Chirality and biological activity
Ketoprofen has one stereogenic center in the side chain and hence exists as mirror-image twins. Majority of the
History
The earliest report of therapeutic use in humans is in 1972.[21]
Society and culture
Brand names
Brand names in Australia include Orudis and Oruvail. It is available in Japan in a transdermal patch Mohrus Tape, made by Hisamitsu Pharmaceutical. It is available in the UK as Ketoflam and Oruvail, in Ireland as Fastum Gel, in Estonia as Keto, Ketonal, and Fastum Gel, in Finland as Ketorin, Keto, Ketomex, and Orudis; in France as Profénid, Bi-Profénid, Toprec, and Ketum; in Italy as Ketodol, Fastum Gel, Lasonil, Orudis and Oki; in Greece as Okitask; in Poland as Ketonal, Ketonal active, Ketolek, in Serbia, Slovenia and Croatia as Knavon and Ketonal; in Romania as Ketonal and Fastum Gel; in Mexico as Arthril; in Norway as Zon and Orudis; in Russia as ОКИ (OKI), Fastum Gel and Ketonal; in Spain as Actron and Fastum Gel; in Albania as Oki and Fastum Gel and in Venezuela as Ketoprofeno as an injectable solution of 100 mg and 150 mg capsules.
In some countries, the optically pure (S)-enantiomer (dexketoprofen) is available; its trometamol salt is said to be particularly rapidly reabsorbed from the gastrointestinal tract, having a rapid onset of effects.
Veterinary medicine
Ketoprofen is a common NSAID,
In horses, it is given at a dose of 2.2 mg/kg/day. Studies have shown that it does not inhibit
Ecological problems
Experiments have found ketoprofen, like diclofenac, is a veterinary drug causing lethal effects in red-headed vultures. Vultures feeding on the carcasses of recently treated livestock develop acute kidney failure within days of exposure.[27]
References
- FDA. Retrieved 22 October 2023.
- ^ "Health product highlights 2021: Annexes of products approved in 2021". Health Canada. 3 August 2022. Retrieved 25 March 2024.
- S2CID 25309841.
- ISBN 9783527607495.
- PMID 16078335.
- S2CID 30719197.
- ^ PMID 20087696.
- PMID 23711416.
- PMID 28540716.
- PMID 27103611.
- ^ a b This article incorporates text from this source, which is in the public domain: "FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications". U.S. Food and Drug Administration (FDA) (Press release). 15 October 2020. Retrieved 15 October 2020.
- ^ a b This article incorporates text from this source, which is in the public domain: "NSAIDs may cause rare kidney problems in unborn babies". U.S. Food and Drug Administration. 21 July 2017. Retrieved 15 October 2020.
- S2CID 43774709.
- ^ a b Ketoprofen. (n.d.). Millennium Web Catalog. Retrieved 1 February 2010, from http://0-online.lexi.com.library.touro.edu Archived 29 August 2021 at the Wayback Machine
- ^ Lemke TL, Williams DA, Roche VF, Zito SW. Foyes Principles of Medical Chemistry. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2008.
- ^ Ketoprofen. (n.d.). Micromedex. Retrieved 1 February 2010, from https://bb-tuc.touro.edu/webapps/portal/frameset.jsp?tab_id=_102_1 Archived 20 July 2011 at the Wayback Machine
- PMID 18689771.
- S2CID 40669413.
- PMID 3276314.
- OCLC 35262289.
- PMID 4564764.
- OCLC 1360077554
- PMID 6089840.
- ^ Betley M, Sutherland SF, Gregoricka MJ, Pollet RA (1991). "The analgesic effect of ketoprofen for use in treating equine colic as compared to flunixin meglumine". Equine Pract. 13: 11–16.
- ^ Owens JG, Kamerling SG, Keowen ML (1994). Anti-inflammatory effects and pharmacokinetics of ketoprofen in a model of equine synovitis. Proceedings of the 6th International Congress of the EAVPT. Blackwell Scientific Publications. pp. 170–171.
- PMID 8725815.
- PMID 20007163.